跳至主要内容
临床试验/NCT01525056
NCT01525056已完成2 期

Rectal Cancer: Local Staging, Re-staging and Assessment of Lymph Node Metastases Using PET-CT, CT-Perfusion and 3T MRI: A Prospective Feasibility Study

London Health Sciences Centre2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
30
试验地点
2
主要终点
efficacy of PET, CT-perfusion and MRI to stage patients with rectal cancer

研究概览

简要总结

The purpose of this study is to evaluate the accuracy of Positron emission tomography, Computed Tomography perfusion and 3 Tesla MRI in the radiological down-staging of rectal cancer following neoadjuvant chemoradiation. The restaging result obtained by these imaging studies will be compared to standard imaging studies and the histopathology of the surgical specimen. We hypothesize that these 3 imaging modalities will detect lymph node metastases pretreatment better than standard pretreatment scans and will better determine the degree of response of the primary rectal tumor to preoperative chemoradiation.

详细描述

Patient Recruitment:

30 consecutive patients with histologically-proven, non-mucinous rectal cancer will be recruited and stratified into three separate groups as follows:

  • T2 tumors (requiring only surgery)
  • Early T3 tumors (requiring preoperative standard course radiation therapy)
  • Advanced T3 and T4 tumors (requiring preoperative chemoradiation)

Study Protocol:

The pretreatment imaging studies will be performed with a 3T MRI pelvis,PET-CT and CT-Perfusion of the pelvis. The patient will then receive standard treatment consisting of surgery,radiation therapy or a course of neoadjuvant chemoradiation.For patients with T3 and T4 tumors, repeat imaging using all three modalities outlined above will be performed post-treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Rectal cancer, stage T2, T3, T4

排除标准

  • Rectal cancer, stage T1 or metastatic
  • Non-rectal primary cancer invading the rectum
  • Mucinous histology
  • Patient is initially, or becomes a non-surgical candidate during the course of the study
  • Hip prosthesis (affects PET-CT image processing)
  • Allergy to CT contrast or patients with impaired renal function, defined as estimated glomerular filtrate rate (eGFR)< 30 ml/min
  • Prior radiotherapy to the region of the study that would result in overlap of radiation fields
  • Contraindications to MRI
  • Pregnancy

结局指标

主要结局

efficacy of PET, CT-perfusion and MRI to stage patients with rectal cancer

时间窗: 3 years

The patient will undergo imaging studies with PET, CT-perfusion and MRI before and after standard preoperative chemoradiation and these imaging studies will be compared with standard imaging and with the final pathology specimen in order to determine the accuracy of these 3 studies in detecting lymph node metastases and response of the primary tumour to treatment

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Barbara Fisher

Doctor

London Health Sciences Centre

研究点 (2)

Loading locations...

相似试验